معرفی
Theresa M. Raimondo is an Assistant Professor of Biomedical Engineering at Brown University with a secondary appointment in the Division of Biology and Medicine. She holds affiliations with the Legoretta Cancer Center. Her research focuses on designing lipid nanoparticles (LNPs) for RNA-based therapies, including mRNA vaccines and siRNA immunotherapies. Raimondo's work bridges engineering and medicine to enhance drug delivery systems for cancer, immunotherapy, and tissue regeneration.
Education:
- Sc.B. in Chemical and Biochemical Engineering - Brown University, 2011
- Ph.D. in Engineering Sciences - Bioengineering - Harvard University, 2019
- Postdoctoral Training: Koch Institute for Integrative Cancer Research, MIT, under Drs. Daniel Anderson and Robert Langer
Research Interests:
Her lab develops LNPs for targeted drug delivery, optimizing formulations to modulate immune responses and improve therapeutic efficacy. Current projects include adjuvanted mRNA vaccines and siRNA-based cancer therapies. Her work integrates machine learning for lipid discovery and explores biomaterials for regenerative immunotherapies.
Recent Trends in Publications:
Recent work emphasizes mRNA vaccine optimization, nanoparticle-mediated gene silencing, and applications in cancer and muscular dystrophy. Key themes include immune modulation, LNP design, and translational biomedical engineering.
Awards:
- 2022 MIT Marble Center Convergence Scholar Fellowship
- NSF Graduate Research Fellowship
- Harvard University Smith Family Graduate Fellowship
Teaching:
Raimondo teaches courses in Biomedical Engineering Design, Biomaterials, and Regenerative Engineering. She leads the Raimondo Lab, which focuses on translatable nanomedicine and RNA-based therapies.
